Protozoan diseases: Malaria clinical features, management, and prevention

International Encyclopedia of Public Health

Volumn , Issue , 2008, Pages 371-382

  Boggild, A K ^a   Kain, K C ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cerebral malaria; Chemoprophylaxis; Clinical disease; Malaria; Personal protective measures; Plasmodium falciparum; Plasmodium malariae; Plasmodium ovale; Plasmodium vivax; Severe malaria; Vaccine

Indexed keywords

EID: 67049089387     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012373960-5.00490-1     Document Type: Chapter

References (22)

1. Alloueche A., Milligan P., Conway D.J., et al. Protective efficacy of the RTS,S/AS02 Plasmodium falciparum malaria vaccine is not strain specific. American Journal of Tropical Medicine and Hygiene 2003, 68:97-101.
2. Bojang K.A., Milligan P., Pinder M., et al. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: A randomized trial. Lancet 2001, 358:1927-1934.
3. Maguire J.D., Sumawinata I.W., Masbar S., et al. Chloroquine-resistant Plasmodium malariae in south Sumatra, Indonesia. Lancet 2002, 360:58-60.
4. Severe falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 2000, 94(supplement 1):1-90. World Health Organization.
5. Guidelines for the Treatment of Malaria 2006, World Health Organization, World Health Organization, Geneva, Switzerland.
6. Baird J.K. Effectiveness of antimalarial drugs. New England Journal of Medicine 2005, 352:1565-1577.
7. Franco-Paredes C., Santos-Preciado J.I. Problem pathogens: Prevention of malaria in travelers. Lancet Infectious Diseases 2006, 6:139-149.
8. Greenwood B.M., Bojang K., Whitty C.J.M., Targett G.A. Malaria. Lancet 2005, 365:1487-1498.
9. Hewitt K., Stekete R., Mwapas V., et al. Interactions between HIV and malaria in non-pregnant adults: Evidence and implications. AIDS 2006, 20:1993-2004.
10. Leder K., Black J., O'Brien D., et al. Malaria in travelers: A review of the GeoSentinel surveillance network. Clinical Infectious Diseases 2004, 39:1104-1112.
11. Mackintosh C.L., Beeson J.G., Marsh K. Clinical features and pathogenesis of severe malaria. Trends in Parasitology 2004, 20:597-603.
12. Moorthy V.S., Good M.F., Hill A.V.S. Malaria vaccine developments. Lancet 2004, 363:150-156.
13. Schlagenhauf P., Kain K.C. Malaria chemoprophylaxis. Travel Medicine 2007, Elsevier Science, Philadelphia, PA, ch.12. 2nd edn. J. Keystone, P. Kozarsky, H. Nothdurft, D. Freedman, B. Conner (Eds.).
14. Suh K.N., Kain K.C., Keystone J.S. Malaria. Canadian Medical Association Journal 2004, 170:1693-1702.
15. Targett G.A. Malaria vaccines 1985-2005: A full circle?. Trends in Parasitology 2005, 21:499-503.
16. Warrell D.A. Cerebral malaria: Clinical features, pathophysiology, and treatment. Annals of Tropical Medicine and Parasitology 1997, 91:875-884.
17. White N.J. Malaria. Manson's Tropical Diseases 2004, 1205-1295. WB Saunders, London. 21st edn. G.C. Cook, A.I. Zumla (Eds.).
18. - World Health Organization, International Travel and Health, 2007. http://www.who.int/ith.
19. - Centers for Disease Control and Prevention, Malaria. http://www.cdc.gov/malaria.
20. - Centers for Disease Control and Prevention, Treatment of Malaria (Guidelines for Clinicians). http://www.cdc.gov/malaria/diagnosis_treatment/tx_clinicians.htm.
21. - Centers for Disease Control and Prevention, Travelers' Health. http://www.cdc.gov/travel/regionalmalaria/index.htm.
22. - Centers for Disease Control and Prevention, CDC Health Information for International Travel, 2008. http://wwwn.cdc.gov/travel/contentYellowBook.aspx.